Im a latecomer to this stock but I've read the announcements regarding the mobvoi partnership and as far as I can figure out it seems like a few investors are just confusing the conneqt release (Q2 22) and its clinical grade blood pressure monitoring with the mobvoi release (Q4 21) and its health application algorithms.
Full transparency from what I can see.
If I can work it out after holding for only a few months, surely the long term holder must be across this by now?
A leason in measure twice cut once, perhaps?
Add to My Watchlist
What is My Watchlist?
